Overview

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of entinostat on heart rate and other electrocardiogram parameters. This study will also evaluate the safety and tolerability of entinostat, as well as pharmacokinetic and pharmacodynamic parameters.
Phase:
Phase 1
Details
Lead Sponsor:
Syndax Pharmaceuticals
Treatments:
Entinostat
Histone Deacetylase Inhibitors